Non small cell lung cancer (NSCLC). A prospective randomized trial with alternating chemotherapy CEP/MEC' versus no treatment
Authors:
- Diego TummarelloDTDiego Tummarello
- Emilio PorfiriEPEmilio Porfiri
- Francesco GuidiFGFrancesco Guidi
- Pierpaolo IsidoriPIPierpaolo Isidori
- Marzio RaspugliMRMarzio Raspugli
- Bruno BiscottiniBBBruno Biscottini
- Giuseppe FatatiGFGiuseppe Fatati
- 1 December 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (12) , 1839-1843
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Advanced non-small-cell lung cancer: to treat or not to treat?Journal of Clinical Oncology, 1987
- Confidence Intervals for Reporting Results of Clinical TrialsAnnals of Internal Medicine, 1986
- Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Phase II Study of the Three-Drug Combination of Mitomycin C, CCNU, and Methotrexate (MCM) in Advanced Non-Small Cell Lung CancerAmerican Journal of Clinical Oncology, 1986
- Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.Journal of Clinical Oncology, 1984
- Moderate Chemo-Radiotherapy in Non-Small Cell Lung Cancer: Results in 21 Patients with Advanced Disease and Low Performance StatusTumori Journal, 1984
- Reporting results of cancer treatmentCancer, 1981
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977